HBW Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

In Brief: Del Pharmaceuticals

This article was originally published in The Tan Sheet

Executive Summary

Del Pharmaceuticals: Revamping Propa pH acne product line by adding an alpha hydroxy acid complex and by increasing the amount of salicylic acid from .5% to 2% in the foaming face wash, peel-off acne mask and maximum strength astringent cleanser. The astringent for normal/sensitive skin will continue to contain .5% salicylic acid. Del is touting the products, which began shipping in June, as the "only acne medication with a moisturizing system" and is repackaging the line to appeal to a unisex audience. Advertising will begin in August...
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

PS084014

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel